Sangamo BioSciences competitorsClear all

Sangamo BioSciences's top competitors include BlueRock Therapeutics, PhaseBio Pharmaceuticals, Actinium Pharmaceuticals and Midatech Pharma.
Sangamo BioSciences
Sangamo BioSciences
Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
BlueRock Therapeutics
BlueRock Therapeutics
BlueRock Therapeutics is an engineered cell therapy company that develops regenerative medicines for intractable diseases.
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
Actinium Pharmaceuticals
Actinium Pharmaceuticals
Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.
Midatech Pharma
Midatech Pharma
Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines.
Founding Date
Founding Date
1995
Founding Date
2016
Founding Date
2002
Founding Date
2000
Founding Date
2000
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Richmond, US HQ
Locations
HQ
Toronto, CA
New York, US
Locations
Malvern, US HQ
Locations
New York, US HQ
Locations
Milton, GB HQ
Cardiff, GB
Milton, GB
Employees
Employees
30266% increase
Employees
N/A
Employees
22
Employees
3020% increase
Employees
8414% increase
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
N/A
Valuation ($)
315.2 m
Valuation ($)
42.1 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
832
Twitter followers
46
Twitter followers
1.4 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
7.5
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
6
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
1120741
Alexa Website Rank
323646
Alexa Website Rank
362969
Alexa Website Rank
326222
Alexa Website Rank
474358

Financial

Revenue (est.)
Revenue (est.)
$84.5m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$668k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
£1.9m (FY, 2018)
Net income
Net income
($68.9m) (FY, 2018)
Net income
N/A
Net income
($23.8m) (FY, 2018)
Net income
($23.7m) (FY, 2018)
Net income
(£10.4m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 74.2m
Total funding raised
$ 225m
Total funding raised
N/A
Total funding raised
$ 7m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

BlueRock Therapeutics
HQ

BlueRock Therapeutics is an engineered cell therapy company that develops regenerative medicines for intractable diseases.

View company
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22

PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.

View company
Actinium Pharmaceuticals
HQ
New York, US
Employees
30↑ 20% increase

Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.

View company
Midatech Pharma
HQ
Milton, GB
Employees
84↑ 14% increase

Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines.

View company